Attached files
file | filename |
---|---|
EX-99.1 - MEDTOX SCIENTIFIC INC | ex991021010-2.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 10, 2010
MEDTOX
SCIENTIFIC, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
1-11394
|
95-3863205
|
||
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
402
West County Road D, St. Paul, Minnesota
|
55112
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (651) 636-7466
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02. Results
of Operations and Financial Condition
On
February 10, 2010, MEDTOX Scientific, Inc. held its quarterly conference call
and announced results for the fourth quarter and year ended December 31, 2009,
as described in the conference call script attached as Exhibit
99.1.
Item
9.01. Financial
Statements and Exhibits.
(c)
|
Exhibits.
|
The
following exhibit is filed as part of this report:
Exhibit No.
|
Description
|
|
99.1
|
MEDTOX
Scientific, Inc. conference call script dated February 10,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
MEDTOX Scientific, Inc.
Date: February
16,
2010 By:
/s/ Richard J.
Braun
Name: Richard J.
Braun
Title: Chief
Executive Officer
INDEX
TO EXHIBITS
Exhibit No.
|
Description
|
|
99.1
|
MEDTOX
Scientific, Inc. conference call script dated February 10,
2010.
|